We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$115B
AUM Growth
+$6.24B
Cap. Flow
+$1B
Cap. Flow %
0.87%
Top 10 Hldgs %
23.71%
Holding
4,165
New
247
Increased
1,898
Reduced
1,581
Closed
296

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 8.69%
3 Financials 8.53%
4 Industrials 6.69%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAM
3701
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$61.3K ﹤0.01%
+10,234
New +$61K
EVLV icon
3702
Evolv Technologies
EVLV
$1B
$60.8K ﹤0.01%
19,500
+7,500
+63% +$21.4K
OPK icon
3703
Opko Health
OPK
$1.04B
$60.3K ﹤0.01%
41,295
-2,001
-5% -$2.58K
OABI icon
3704
OmniAb
OABI
$499M
$60.1K ﹤0.01%
16,333
-49
-0.3% -$185
HUMA icon
3705
Humacyte
HUMA
$170M
$60K ﹤0.01%
+19,411
New +$55.2K
GLMD icon
3706
Galmed Pharmaceuticals
GLMD
$4.66M
$58.9K ﹤0.01%
767
CRGE
3707
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$58.7K ﹤0.01%
53,320
-229,943
-81% -$290K
BNBX
3708
DELISTED
BNB PLUS CORP
BNBX
$57.5K ﹤0.01%
3
+1
+50% +$21.5K
PIM
3709
Franklin Master Intermediate Income Trust
PIM
$153M
$56.8K ﹤0.01%
17,877
-22,800
-56% -$74.1K
VBIV
3710
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$55.7K ﹤0.01%
6,127
-652
-10% -$9.24K
VMAR icon
3711
Vision Marine Technologies
VMAR
$3.8M
0
CSCO icon
3712
CALL
Cisco
CSCO
$485B
$55K ﹤0.01%
1,100
-187,800
-99% -$9.17M
AMRN
3713
Amarin Corp
AMRN
$297M
$53.2K ﹤0.01%
1,775
+100
+6% +$3.51K
ONDS icon
3714
Ondas Inc
ONDS
$5.56B
$52.5K ﹤0.01%
48,569
-366
-0.7% -$637
UEC icon
3715
Uranium Energy
UEC
$5.65B
$52K ﹤0.01%
18,043
-17,000
-49% -$61.5K
SCYX icon
3716
SCYNEXIS
SCYX
$48.1M
$51.9K ﹤0.01%
2,162
+360
+20% +$4.79K
WTI icon
3717
W&T Offshore
WTI
$557M
$50.8K ﹤0.01%
+10,007
New +$55.9K
PAVMZ
3718
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$50.3K ﹤0.01%
335,536
-400
-0.1% -$79
HNST icon
3719
The Honest Company
HNST
$545M
$49.5K ﹤0.01%
27,476
-4,000
-13% -$10.9K
PRQR icon
3720
ProQR Therapeutics
PRQR
$268M
$48K ﹤0.01%
22,550
+1,000
+5% +$3.06K
JMIA
3721
Jumia Technologies
JMIA
$780M
$47.6K ﹤0.01%
14,468
+310
+2% +$1.12K
GRWG icon
3722
GrowGeneration
GRWG
$114M
$46.6K ﹤0.01%
13,614
-311
-2% -$1.33K
AMRS
3723
DELISTED
Amyris Inc.
AMRS
$46.3K ﹤0.01%
34,063
-655
-2% -$936
MFV
3724
DELISTED
MFS SPECIAL VALUE TRUST
MFV
$46.1K ﹤0.01%
+10,943
New +$48.1K
BGRY
3725
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$45.5K ﹤0.01%
33,000
+3,000
+10% +$3.57K

Similar funds

Raymond James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James & Associates held 4,165 positions worth $115B, up 5.7% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2023 filing shows 247 new, 1,898 increased, 1,581 reduced and 296 closed positions. Its largest new stake was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2023 buy was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $413M increase.
  • Raymond James & Associates's biggest Q1 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $18.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $115B portfolio in Q1 2023.
  • Raymond James & Associates opened 247 new positions and closed 296 in Q1 2023.
  • Raymond James & Associates's portfolio value rose 5.7% quarter-over-quarter to $115B.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.